Your browser doesn't support javascript.
loading
Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients.
Puñet-Ortiz, Joan; Hervás-García, José Vicente; Teniente-Serra, Aina; Cano-Orgaz, Antonio; Mansilla, Maria José; Quirant-Sánchez, Bibiana; Navarro-Barriuso, Juan; Fernández-Sanmartín, Marco A; Presas-Rodríguez, Silvia; Ramo-Tello, Cristina; Martínez-Cáceres, Eva María.
Afiliação
  • Puñet-Ortiz J; Division of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain.
  • Hervás-García JV; Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Spain.
  • Teniente-Serra A; Department of Neuroscience, Multiple Sclerosis Unit, University Hospital Germans Trias i Pujol, Badalona, Spain.
  • Cano-Orgaz A; Division of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain.
  • Mansilla MJ; Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Spain.
  • Quirant-Sánchez B; Neurology Service, Consorci Sanitari del Maresme, Mataró, Spain.
  • Navarro-Barriuso J; Division of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain.
  • Fernández-Sanmartín MA; Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Spain.
  • Presas-Rodríguez S; Division of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain.
  • Ramo-Tello C; Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Spain.
  • Martínez-Cáceres EM; Division of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, Badalona, Spain.
Cytometry B Clin Cytom ; 94(2): 327-333, 2018 03.
Article em En | MEDLINE | ID: mdl-28378895

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Integrina alfa4 / Anticorpos Monoclonais Humanizados / Natalizumab / Esclerose Múltipla Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Integrina alfa4 / Anticorpos Monoclonais Humanizados / Natalizumab / Esclerose Múltipla Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2018 Tipo de documento: Article